Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 24Breast Neoplasms 13Triple Negative Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Thymoma 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Locally Advanced Pancreatic Cancer 2Borderline Resectable Pancreatic Cancer 2Biliary Tract Neoplasms 2Advanced Pancreatic Cancer 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Thromboembolism 1Thoracic Neoplasms 1Stage IV Gastric Cancer With Metastasis 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Lung 1Small Cell Lung Carcinoma 1Resectable Biliary Tract Cancer 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Muscle-Invasive Bladder Carcinoma 1Melanoma 1Lung Diseases 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Locally Advanced Cervical Carcinoma 1

Interventions

icotinib 1Taxes 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Squamous Cell Carcinoma of Lung × 130-nm albumin-bound paclitaxel × Clear all
NCT01969955 2014-04-25

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

ChineseAMS

Phase 2 Unknown
50 enrolled

Squamous Cell Carcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡